Cite

APA Citation

    Pawlyn, C., & Bird, S. (2022). lenalidomide and risk of second primary malignancy—is disease context key?. Lancet, 9(12), e868–e869. http://access.bl.uk/ark:/81055/vdc_100170509680.0x00000a
  
Back to record